Browse the evidence

Inclusion of genetic risk information in personalized nutrition advice does not significantly improve dietary changes, lifestyle behaviors, or weight loss outcomes compared to generic advice.

Do not pay for expensive genetic testing to guide your diet. Large studies show that knowing your genetic risk for obesity or diabetes does not help you lose weight or eat better than standard healthy eating advice. Focus on proven behavioral strategies like tracking intake and physical activity instead.

Telehealth-delivered dietary interventions for chronic disease management are frequently reported with insufficient detail, preventing accurate interpretation of trial results and implementation in clinical practice.

If you are a clinician looking to implement a telehealth dietary program based on a research paper, do not assume the published description is sufficient. You must actively seek out the full protocol, supplementary materials, or contact the authors directly, as most publications omit critical details about materials, tailoring, and fidelity.

Standard long-term weight management RCTs for severe obesity (BMI ≥35 kg/m2) systematically exclude or underrepresent underserved groups (low SES, racial minorities, mental health conditions), rendering the evidence base non-generalizable to the populations most at risk of severe obesity.

Current weight management guidelines for severe obesity are largely based on research that excludes the people who need them most (those with lower income, mental health issues, or minority backgrounds). If you belong to an underserved group, standard advice may not work for you because it wasn't tested on people like you. Seek programs that explicitly adapt to your cultural, socioeconomic, and logistical needs, rather than assuming standard protocols will be effective.

Intensive lifestyle interventions (diet and exercise) aiming for weight loss and increased physical activity do not significantly reduce cardiovascular morbidity or mortality in patients with type 2 diabetes compared to standard care, despite improving surrogate markers.

While diet and exercise are crucial for feeling better and managing blood sugar, do not rely on them alone to prevent heart attacks or death in type 2 diabetes. You likely need medication to manage blood pressure and lipids alongside lifestyle changes to protect your heart.

Self-reported weight and height data significantly overestimates obesity prevalence compared to professional anthropometric measurements, rendering self-perception an inadequate tool for population-level nutritional classification.

Do not rely on your own memory of your weight and height for health decisions. Self-reports are statistically unreliable for detecting obesity. If you are concerned about your nutritional status, get measured by a professional using calibrated scales and stadiometers, as self-reporting tends to overestimate obesity prevalence by missing the true extent of the issue.

Obtaining a home scale with advanced features (digital connectivity or high weight capacity >400 lbs) is significantly more expensive and less available than basic scales, creating a financial and accessibility barrier for patients requiring these specific features for self-weighing.

If you need to self-weigh but have a higher body weight or need to sync data with your doctor, basic scales may not work for you. These specialized scales cost significantly more ($40-$50+ vs $20-25). Talk to your clinician about whether insurance might cover the cost, or look for the most affordable option that meets your specific weight and connectivity needs.

Existing patient-reported outcome (PRO) measures for obesity fail to capture key appetite and eating behavior concepts (e.g., duration of fullness, satisfaction after eating, eating between meals) that are relevant to individuals with obesity and likely to change with treatment.

If you are managing obesity, standard questionnaires might miss how you actually feel after eating (satisfaction, fullness duration). This gap means your provider might not fully understand your specific challenges with cravings or portion control. A comprehensive assessment tool (like the EBAQ) can better capture these nuances to tailor your treatment plan.

Primary care physicians systematically overestimate the mortality risk associated with being overweight (BMI 25–29.9), perceiving a significantly higher risk increase than what current meta-analytic evidence supports.

Physicians should be aware that their perception of mortality risk for overweight patients (BMI 25-29.9) is likely inflated compared to actual population data. This overestimation may lead to unnecessary alarm or aggressive interventions for patients who are not obese. Counseling should focus on overall health metrics rather than BMI categories alone, recognizing that the mortality risk for 'overweight' is modest and inconsistent across studies.

Telephone health coaching (THC) does not significantly reduce long-term (8-year) composite cardiovascular morbidity or mortality in intention-to-treat analysis for patients with Type 2 Diabetes, Coronary Artery Disease, or Congestive Heart Failure.

If you have diabetes or heart disease, phone coaching alone is unlikely to prevent heart attacks or death unless you actively engage with the process. The study showed no benefit for the general group receiving the coaching. However, those who actually participated in the sessions (per-protocol) did see benefits, suggesting that your active involvement is the key driver, not the phone calls themselves.

Approximately 11.5% of patients undergoing secondary metabolic bariatric surgery (MBS) transfer to a different hospital than their primary procedure, a rate that is underestimated in single-institution registries.

If you are considering secondary bariatric surgery, be aware that about 11% of patients switch hospitals for this procedure. This is often driven by dissatisfaction with weight regain or complications from the first surgery. You are not alone in seeking a second opinion or a different provider if you feel your current care is not meeting your expectations.

Kinovea video analysis software does not provide interchangeable or accurate measurements of barbell velocity, duration, or range of motion compared to the validated Open Barbell System (OBS) for free-weight resistance training exercises.

Do not use Kinovea to prescribe weights or determine when to stop a set based on velocity. It systematically overestimates speed and range of motion in free-weight lifts because it tracks the total path of the bar (including horizontal movement) rather than just vertical displacement. Use a validated linear position transducer (like the Open Barbell System) or percentage-based training if you cannot afford velocity equipment.

Poststratification of UK Biobank data to match general population demographics reveals that the protective association between heavy alcohol consumption and cardiovascular disease (CVD) mortality observed in unweighted analyses is spurious and disappears.

If you drink heavily (≥5 times/week), do not rely on alcohol for heart health. The perceived protective effect seen in older studies likely disappears when looking at the general population. Focus on proven lifestyle factors like physical activity and diet for cardiovascular protection.

Cohort unrepresentativeness in the UK Biobank leads to an underestimation of the mortality risk associated with the least healthy cumulative lifestyle profiles.

If you have an unhealthy lifestyle (poor diet, low activity, smoking), the risk to your life is likely higher than general statistics suggest. Correcting for population biases shows a 9% increase in mortality risk for the least healthy groups. Prioritize improving these factors to mitigate this hidden risk.

Obesity should be clinically classified as a chronic, progressive, and relapsing disease rather than a lifestyle choice or mere risk factor, which is necessary to combat stigma and promote effective long-term management.

Understand that obesity is a chronic medical condition, not a character flaw. This means it requires long-term management strategies similar to other chronic diseases like hypertension or diabetes, rather than short-term 'fixes' based on willpower. Seek care from providers who view it as a disease to manage, not a failure to overcome.

Produce prescription programs do not significantly change BMI z-score in children, despite improvements in fruit and vegetable intake and food security.

While produce prescription programs improve diet and food security for children, they may not immediately impact BMI z-score. Focus on the overall health benefits and improved access to nutritious food rather than expecting immediate changes in weight metrics.

Living in less walkable neighborhoods is associated with lower systolic blood pressure, higher HDL cholesterol, and lower likelihood of diabetes, but also lower likelihood of smoking.

While walkable areas might have higher smoking rates, the overall cardiovascular risk is still lower due to the benefits of daily physical activity. If you live in a walkable area, be aware of tobacco availability and consider cessation support. If you live in a less walkable area, prioritize active transport options to offset the higher CVD risk.

When inequalities in behavioral weight management interventions do exist, they tend to favor 'more advantaged' groups (e.g., older, higher SES, employed) in terms of trial uptake, intervention adherence, and trial attrition.

If you are from a 'less advantaged' background (e.g., lower income, rural, younger), you may face higher barriers to starting or sticking with a weight loss program. This is not a reflection of your ability but of the program's design requiring high personal agency. Seek programs that reduce these barriers.

Approximately half of patients with type 2 diabetes discontinue SGLT-2 inhibitors or GLP-1 receptor agonists within five years, but a significant portion (approx. 25%) reinitiates therapy within one year of discontinuation, suggesting many discontinuations are temporary pauses rather than permanent abandonment.

If you stop your SGLT-2 inhibitor or GLP-1 RA, it doesn't mean you are done with it. About 1 in 4 people restart within a year. This often happens after a hospital stay. If you pause your medication due to illness or surgery, ask your doctor to help you restart it as soon as it is safe, so you don't lose the long-term heart and kidney benefits.

Adding phenotypic and genotypic data to personalized nutrition advice does not provide added benefit over advice based solely on current diet analysis.

Do not pay for expensive genetic or phenotypic testing for personalized nutrition advice. The Food4Me study showed that advice based only on your current diet is just as effective as advice that includes your genes or body metrics.

Providing individualized genetic risk information alone does not motivate behavior change in diet or physical activity.

Do not rely on genetic testing to motivate you to eat better or exercise. Knowing your genetic risk does not change your behavior. Focus on actionable dietary advice instead.

A 12-month multi-component exercise program combined with daily multi-nutrient supplementation (whey protein, calcium, vitamin D) has limited effect on ameliorating adverse musculoskeletal consequences (bone density, muscle mass, physical function) in men with prostate cancer undergoing androgen deprivation therapy, primarily due to modest intervention adherence.

For men on prostate cancer hormone therapy, combining exercise and supplements is challenging to maintain long-term. While leg strength can improve, bone density loss often continues. Prioritize sustainable adherence over complex protocols; if you can't do 3 gym sessions and take daily supplements, focus on what you can consistently do, as the study showed low adherence led to negligible bone benefits.

Nutrition-sensitive programs that utilize direct food transfers or asset transfers (such as livestock or poultry) yield the largest improvements in micronutrient intake (iron, zinc, vitamin A, animal protein) for children under five, but incur significantly higher costs per child reached compared to programs focused on education, media campaigns, or market access.

For maximum nutritional impact in resource-poor settings, direct provision of food or productive assets (like livestock or seeds) to families with young children is more effective at closing critical nutrient gaps (iron, zinc, vitamin A) than education or cash alone. However, this comes at a significantly higher financial cost. Decision-makers must weigh the higher immediate expense against the greater health benefits for children, recognizing that cheaper education-only programs may not sufficiently improve dietary quality.

An intensive lifestyle intervention (ILI) for weight loss in adults with type 2 diabetes and overweight/obesity is not cost-effective over a 9-year period compared to standard diabetes support and education (DSE), as the high cost of delivering the intervention is not offset by sufficient gains in quality-adjusted life years (QALYs).

For patients with type 2 diabetes, intensive lifestyle changes (like losing 7% of body weight) do improve health markers and may save some medical costs, but the program itself is expensive to run. Over 9 years, the health benefits (QALYs) gained are small and may not justify the high cost of intensive counseling for everyone. However, for individuals who prefer to avoid medication, lifestyle modification remains a valid, effective option for improving blood sugar and blood pressure, even if it is not 'cost-effective' from a system-wide perspective.

Consumers exhibit significantly higher skepticism toward food advertisements than toward food labels, yet remain generally skeptical of both, including the Nutrition Facts Panel (NFP).

Do not assume that seeing a Nutrition Facts Panel or a government-regulated label automatically means a consumer will trust or use it. Consumers are skeptical of both ads and labels, though they trust labels slightly more. To improve adherence, labels must be designed to overcome this inherent skepticism, perhaps by being clearer and less misleading, rather than relying on the assumption that regulation alone builds trust.